Maybe not "plodding along"for much longer. I recently met with mgmt with regards to the recent CR ; the company had been held back by a lack of cash available for development - that issue has now been addressed.
The potential opportunity here is very large, relative to the current mkt cap IMO .
- Forums
- ASX - By Stock
- STX
- Ann: Quarterly Activities Report and Appendix 5B-STX.AX
Ann: Quarterly Activities Report and Appendix 5B-STX.AX, page-16
Featured News
Add STX (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.3¢ |
Change
0.003(1.14%) |
Mkt cap ! $630.3M |
Open | High | Low | Value | Volume |
22.0¢ | 22.5¢ | 22.0¢ | $229.9K | 1.035M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
29 | 2205804 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 1198328 | 17 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
29 | 2206637 | 0.220 |
20 | 993422 | 0.215 |
25 | 1325603 | 0.210 |
21 | 1255749 | 0.205 |
34 | 992585 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 1219665 | 17 |
0.230 | 4515457 | 18 |
0.235 | 1718865 | 25 |
0.240 | 2917378 | 23 |
0.245 | 2500130 | 21 |
Last trade - 13.18pm 13/11/2024 (20 minute delay) ? |
Featured News
STX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online